Press Releases
Events & Presentations
Corporate Governance
Financial Information
Stock Information
Investor FAQs
Contact Us
Investors  >  Events & Presentations

Events & Presentations

Enzymotec's Extraordinary General Meeting of Shareholders
Apr 25, 2017
PDF Proxy Statement  495.6 KB   Add to Briefcase
PDF Proxy Card  162.8 KB   Add to Briefcase

Back to previous page

  Home Page | Site Map | Contact Us  
Signed by CDTech - Web Development and Design  
Disclaimer: These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat , cure or prevent disease.
Copyright (©) 2013 Enzymotec Ltd. All rights reserved.